Real-World Analysis on Second-Line Cetuximab in mCRC Reveals Factors Linked With Longer Time on Treatment, OS – OncLive
CONTEXT: Report of data presented at ASCO 2021 on cetuximab in metastatic colorectal cancer (mCRC) | US only data IMPACT: Low READ TIME: 2 mins Quality Level Mean [1 – Continue Reading